Literature DB >> 18852713

Myocardial protection: is primary PCI enough?

Derek J Hausenloy1, Derek M Yellon.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18852713     DOI： 10.1038/ncpcardio1371

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN： 1743-4297


× No keyword cloud information.
  8 in total

Review 1.  Myocardial reperfusion injury.

Authors:  Derek M Yellon; Derek J Hausenloy
Journal:  N Engl J Med       Date:  2007-09-13       Impact factor: 91.245

2.  Time to take myocardial reperfusion injury seriously.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

Review 3.  Remote ischaemic preconditioning: underlying mechanisms and clinical application.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2008-05-02       Impact factor: 10.787

4.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction.

Authors:  Christophe Piot; Pierre Croisille; Patrick Staat; Hélène Thibault; Gilles Rioufol; Nathan Mewton; Rachid Elbelghiti; Thien Tri Cung; Eric Bonnefoy; Denis Angoulvant; Christophe Macia; Franck Raczka; Catherine Sportouch; Gerald Gahide; Gérard Finet; Xavier André-Fouët; Didier Revel; Gilbert Kirkorian; Jean-Pierre Monassier; Geneviève Derumeaux; Michel Ovize
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

5.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

Authors:  Zhi-Qing Zhao; Joel S Corvera; Michael E Halkos; Faraz Kerendi; Ning-Ping Wang; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

6.  Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.

Authors:  Masafumi Kitakaze; Masanori Asakura; Jiyoong Kim; Yasunori Shintani; Hiroshi Asanuma; Toshimitsu Hamasaki; Osamu Seguchi; Masafumi Myoishi; Tetsuo Minamino; Takahiro Ohara; Yoshiyuki Nagai; Shinsuke Nanto; Kouki Watanabe; Shigeru Fukuzawa; Atsushi Hirayama; Natsuki Nakamura; Kazuo Kimura; Kenshi Fujii; Masaharu Ishihara; Yoshihiko Saito; Hitonobu Tomoike; Soichiro Kitamura
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

7.  Long-term benefit of postconditioning.

Authors:  Hélène Thibault; Christophe Piot; Patrick Staat; Laurence Bontemps; Catherine Sportouch; Gilles Rioufol; Thien Tri Cung; Eric Bonnefoy; Denis Angoulvant; Jean-François Aupetit; Gérard Finet; Xavier André-Fouët; Jean Christophe Macia; Franck Raczka; Rolland Rossi; Rolland Itti; Gilbert Kirkorian; Geneviève Derumeaux; Michel Ovize
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

Review 8.  Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214
  8 in total
  2 in total

Review 1.  Concepts of hypoxic NO signaling in remote ischemic preconditioning.

Authors:  Matthias Totzeck; Ulrike Hendgen-Cotta; Tienush Rassaf
Journal:  World J Cardiol       Date:  2015-10-26

2.  Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.

Authors:  Siavash Beikoghli Kalkhoran; Janos Kriston-Vizi; Sauri Hernandez-Resendiz; Gustavo E Crespo-Avilan; Ayeshah A Rosdah; Jarmon G Lees; Joana Rodrigues Simoes Da Costa; Naomi X Y Ling; Jessica K Holien; Parisa Samangouei; Kroekkiat Chinda; En Ping Yap; Jaime A Riquelme; Robin Ketteler; Derek M Yellon; Shiang Y Lim; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.